Current location:Global Gateway news portal > health
The cancer drugs that could improve survival rates if given to patients in the morning
Global Gateway news portal2024-05-22 11:17:05【health】8People have gathered around
IntroductionGiving cancer patients immunotherapy early in the morning rather than in the afternoon could improve
Giving cancer patients immunotherapy early in the morning rather than in the afternoon could improve survival rates.
A study has found that people with terminal lung or skin cancers lived twice as long if they received immunotherapy drugs — which help the immune system destroy cancer cells — at the start of the day instead of after lunchtime.
The best results were seen in those treated at about 7.30am. They lived on average another two-and-a-half years.
The researchers who led the trial, published in the European Journal of Cancer, think this may be due to the immune system being more active very early in the day.
Previous studies found there are higher levels of immune cells circulating in the blood in the early morning.
Giving cancer patients immunotherapy early in the morning rather than in the afternoon could improve survival rates, a new study has found (Stock Image)
Immunotherapy drugs stop the proteins from binding to T-cells, effectively turning the immune system back on, enabling it to seek and destroy cancerous growths. Pictured: A graphic showing cancer cells
As well as fighting off viruses and bacteria, these can attack cancer cells.
It's thought this is due to the circadian rhythm — our body clock — getting the immune system ready to face any daytime threats from infectious agents, such as in food or transmitted via interacting with people around us.
READ MORE: Alarm over insulin shortage as Brits battling type 1 diabetes fear they'll 'die within days' without access to life-saving drug
AdvertisementImmunotherapy drugs, such as ipilimumab, pembrolizumab and nivolumab, have transformed cancer care in the UK over the past decade or so.
Since 2011 when the first immunotherapy drugs were licensed in the UK for the treatment of malignant melanoma (the most dangerous form of skin cancer), average survival time has risen from six months to five years or more.
Most of these drugs — which can cost up to £100,000 per patient per year — work by attaching to a protein called PD-L1, which is produced in large quantities by cancer cells.
The protein switches off T-cells, defender cells released by the immune system, rendering them unable to attack the cancer.
Immunotherapy drugs stop the proteins from binding to T-cells, effectively turning the immune system back on, enabling it to seek and destroy cancerous growths.
The theory is that giving immunotherapy at the start of the day would supercharge this response, as there are more T-cells circulating then.
This follows previous research that showed people given the flu vaccine early in the day produced much higher levels of antibodies than those given the jab later.
Again, the thinking is that the immune system is more active then, so responds much more vigorously to vaccines.
The researchers, from a number of bodies in France — including the PSL Research University in Paris — analysed data from 361 patients with lung or skin cancer that had spread and who were treated with immunotherapy drugs between 2015 and 2021.
Their survival rates were compared with the usual time each patient received treatment — most had roughly the same slot every week or two weeks.
The theory is that giving immunotherapy at the start of the day supercharges a person's immune response, as there are more T-cells then. Picture: Molecular model of an antibody
The results showed those treated before noon survived an average of 30 months; after that average survival was 15.9 months.
Earlier studies also involving the timing of cancer treatments reached similar conclusions.
Now two larger trials are under way in China and the U.S. to see if more lives could be saved just by giving drugs in the morning. The results are expected in the next couple of years.
Dr Pasquale Innominato, a cancer specialist at Ysbyty Gwynedd Hospital in Bangor, Wales, who is also researching the effect of earlier drug delivery, said the findings have the potential to shake-up NHS patient care.
'We need to see results from the bigger trials, but all the evidence so far shows that, whatever type of immunotherapy drug is used and whatever type of cancer it is, there are benefits from giving treatment earlier in the day.'
Address of this article:http://ukraine.camilleandconfettis.com/article-95d199718.html
Very good!(6)
Related articles
- A tiny Michigan town's century
- AP Week in Pictures: Europe and Africa
- Olivares, Gonzales homer to lead Pirates to 5
- Childhood friend asks for help to solve mystery death of 'caring and loving' mother
- Freshman Jasen Oliver drives in 4 and Indiana holds off Purdue 8
- Federal agency takes control of investigation of fiery train derailment in New Mexico
- Suspected militants bomb a girl's school overnight in northwest Pakistan
- Yemen's Houthi rebels claim shooting down another US MQ
- Israel addressed Biden’s concerns over widescale Rafah operation: US official
- Terrifying moment knife
Popular articles
- 'Top two' primary election measure makes South Dakota's November ballot
- Disability rights advocate says state senator with violent history shoved him at New York Capitol
- Mark Hanson, Bricoleur Vineyards owner, is accused of raping and abusing his younger sister over six
- Global obesity deaths rise by 50 percent since 2000, major report shows
Recommended
Maker of popular weedkiller amplifies fight against cancer
8 EU members say conditions in Syria should be reassessed to allow voluntary refugee returns
Nuclear war expert reveals what would really happen after an atomic blast
The real cost of your night out: From a £4.60 Diet Coke to £8.80
Emma Weymouth channels wedding chic in a white gown at Cannes Film Festival
Vermont to grant professional licenses, regardless of immigration status, to ease labor shortage
Scottie Scheffler arrested at PGA Championship, returns to course
Vermont to grant professional licenses, regardless of immigration status, to ease labor shortage
Links
- Police fatally shoot a man who sliced an officer's face during a scuffle
- 26 Republican attorneys general sue to block Biden rule requiring background checks at gun shows
- Biden to travel to North Carolina to meet with families of officers killed in deadly shooting
- Biden administration weighing measures to help Palestinians bring family from region
- Biden administration weighing measures to help Palestinians bring family from region
- Biden to travel to North Carolina to meet with families of officers killed in deadly shooting
- Russell Wilson and Ciara find a buyer for $25m, 11,000sq ft mansion near Seattle
- US job openings fall to 8.5 million in March, the lowest level in more than 3 years
- Ross Stripling earns his first win since 2022 as Athletics blank Pirates 4
- Georgia governor signs law requiring jailers to check immigration status of prisoners